Related Experiment Video

Updated: May 17, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Virological response for recurrent hepatitis C improves long-term survival in liver transplant recipients

Tomohiro Tanaka1, Nazia Selzner, George Therapondos

  • 1Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

Transplant International : Official Journal of the European Society for Organ Transplantation
|November 10, 2012
PubMed

Insights

Achieving a sustained virological response (SVR) after hepatitis C virus (HCV) treatment significantly improves long-term survival for liver transplant recipients. Early virological response is critical for better patient outcomes post-transplant.

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Virology

Background:

  • Recurrent hepatitis C virus (HCV) infection is a primary cause of mortality following liver transplantation (LT) for HCV-related end-stage liver disease.
  • Effective management of post-transplant HCV recurrence is crucial for improving LT recipient survival.

Purpose of the Study:

  • To evaluate the long-term impact of antiviral treatment response on the survival of liver transplant recipients with recurrent hepatitis C.
  • To determine if sustained virological response (SVR) or relapse influences patient survival rates after LT.

Main Methods:

  • A retrospective study of 245 LT recipients treated with interferon-based antiviral therapy for recurrent HCV from August 1987 to October 2011.
  • Kaplan-Meier survival analysis was used to compare outcomes between patients achieving SVR, relapsers, and non-responders (NR).
  • Patient survival was assessed based on virological response status, independent of other characteristics.

Main Results:

  • Sustained virological response (SVR) was achieved by 51.4% of patients.
  • Patients with SVR demonstrated significantly better 5-year survival (95.2%) compared to the non-response (NR) group (49.9%) (P < 0.001).
  • Relapsers showed significantly longer survival than the NR group (P = 0.005), and a trend towards better survival than NR group (P = 0.14).

Conclusions:

  • Virological response to antiviral therapy, particularly SVR, is a significant predictor of improved long-term patient survival after LT for hepatitis C.
  • Achieving SVR markedly improves patient outcomes, highlighting the importance of successful HCV eradication post-transplantation.
  • Antiviral treatment response is a key factor in managing recurrent HCV and enhancing survival in LT recipients.

More Related Videos

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Vascular Reconstruction with the Cuff Technique in Mouse Orthotopic Liver Transplantation05:25

Vascular Reconstruction with the Cuff Technique in Mouse Orthotopic Liver Transplantation

Published on: December 1, 2023

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...